Featured Research

from universities, journals, and other organizations

Scottish data highlight dangerous practice in pediatric paracetamol prescribing

Date:
May 18, 2011
Source:
Wiley-Blackwell
Summary:
Many of the prescriptions issued by GPs for paracetamol either give less than recommended doses to older children or exceed recommended doses in young children. Under-dosing may result in insufficient pain relief and over-dosing can damage a person's liver. "Getting the dose right can become even more complicated when parents also give their children additional paracetamol that they have bought over the counter," says James McLay, a senior member of the research team who studied this issue.

Many of the prescriptions issued by GPs for paracetamol either give less than recommended doses to older children or exceed recommended doses in young children. Under-dosing may result in insufficient pain relief and over-dosing can damage a person's liver. "Getting the dose right can become even more complicated when parents also give their children additional paracetamol that they have bought over the counter," says James McLay, a senior member of the research team who studied this issue.

The findings are published in the British Journal of Clinical Pharmacology.

Paracetamol is the single most frequently used medicine that people take for managing fever and pain, with over four-fifths of infants in the UK having at least one dose of it before they are six months old. Judging how much paracetamol to give an infant is not straight forward, because you need to take into account both the baby's age and weight. One consequence is that doctors ought to check the right dose to use on each occasion by checking with the multiple dosage recommendations in formularies such as the British National Formulary for Children (BNFc).

A team of researchers in Scotland set out to see how well General Practice doctors followed guidelines when writing out prescriptions. Team members were based in the division of health sciences at the University of Aberdeen and the Division of Applied Health Sciences Centre for Population Health Science at the University of Edinburgh, Edinburgh.

Their source of data was the 35,839 children aged 0 to 12 years old who were listed in Scottish Practice Team Information database in 2006. Of these, 2,761 had been issued with 4,423 prescriptions for paracetamol. Almost one in 20 children had been given an excessive dose during that year. When they just looked at infants in the 0-3 age range, the incidence rose to one in four. At the same time, about a quarter of children aged 6-12 were under dosed. One in eight prescriptions failed to include any dosage instructions at all.

"This is the first study to describe the patterns of paracetamol prescribing by primary care physicians in the community, and it is worrying to discover that just over half of the prescriptions failed to comply with current BNFc recommendations," says McLay, who believes that although the data was collected in Scotland, there is a high chance that prescribing practice is similar wherever doctors write prescriptions for paracetamol.

Dr McLay and his team believe that health care workers have an important role in helping people use paracetamol safely. Part of this can be shown if they deliberately take care when calculating the correct dose. "We know from other studies that around half of parents do not understand official dosage recommendations for medicines such as paracetamol, and not taking care over dosing instructions can leave parents in a state of confusion, or strengthen the public perception that paracetamol is harmless," says McLay.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Scottish data highlight dangerous practice in pediatric paracetamol prescribing." ScienceDaily. ScienceDaily, 18 May 2011. <www.sciencedaily.com/releases/2011/05/110518191517.htm>.
Wiley-Blackwell. (2011, May 18). Scottish data highlight dangerous practice in pediatric paracetamol prescribing. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/05/110518191517.htm
Wiley-Blackwell. "Scottish data highlight dangerous practice in pediatric paracetamol prescribing." ScienceDaily. www.sciencedaily.com/releases/2011/05/110518191517.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins